MedPath

PULMICORT

These highlights do not include all the information needed to use PULMICORT FLEXHALER™ safely and effectively. See full prescribing information for PULMICORT FLEXHALER™. PULMICORT FLEXHALER™ 90 MCG, 180 MCG (BUDESONIDE INHALATION POWDER) Initial U.S. Approval: 2006

Approved
Approval ID

0950cd08-a48b-4376-9647-da22cf5a8a70

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 6, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Budesonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-291
Application NumberNDA021949
Product Classification
M
Marketing Category
C73594
G
Generic Name
Budesonide
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJuly 29, 2010
FDA Product Classification

INGREDIENTS (2)

BUDESONIDEActive
Quantity: 90 ug in 1 1
Code: Q3OKS62Q6X
Classification: ACTIB
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PULMICORT - FDA Drug Approval Details